Search:

Login | Subscribe

Home > Companies > Aqua Bounty Technologies...

Price	Market	Sector	Market Cap
7.00p (0.00p) 0.00%	AIM	Medicine and Biotech Research	£3.5m

Add to company folder | Print

Related Companies

AGY	10.00p	0.00%
APH	4.62p	0.00%
CBF	2.00p	-11.11%
CRX	2.75p	0.00%
EVC	25.75p	0.00%
FUL	3.12p	0.00%
FUM	28.25p	-2.59%
GMX	1.75p	0.00%
GWP	30.00p	0.00%
HML	0.42p	0.00%
MMG	7.25p	0.00%
MPM	14.25p	0.00%
OMH	3.50p	0.00%
PLE	16.50p	0.00%
PRM	20.50p	-8.89%
PRX	145.00p	5.46%
RNSM	7.75p	0.00%
RCG	35.00p	-6.67%
RGT	6.50p	0.00%

Commentary

Develops and markets biotechnology products to enhance the profitability of shrimp and fish farming operations

Recent Articles

New Issues Examined by Oliver Haill	15/05/2006
Newcomer - Aqua Bounty Technologies	20/03/2006

Recent Announcements

Comment on Company Share Pric	08/09/2008
Operations update	15/08/2008
Result of AGM	29/07/2008
Issues of Shares and Options	08/07/2008
Management Change	08/07/2008
Annual Report and Accounts	30/06/2008
Notice of AGM	11/06/2008
Final Results	14/05/2008
Trading Statement	29/02/2008
New Trials	04/02/2008
More

Articles from the Sector

Stroke hope at ReNeuron	28/11/2008
Futura Medical	28/11/2008
Option deal boosts ImmuPharma	25/11/2008
Digital imager targets AIM	24/11/2008
Vectura loses interim £11.7m	24/11/2008
GW trims loss	19/11/2008
Asterand	18/11/2008
EU trial cheers Plethora	07/11/2008
IS Pharma	05/11/2008
Animalcare nurturing high-margin growth	03/11/2008
More

Financial History

Financial Year End	31/12/2004	31/12/2005	31/12/2006	31/12/2007
Currency	USD	USD	USD	USD
Turnover	0.33	1.32	0.64	0.29
Operating Profit	-2.98	-5.14	-7.92	-7.89
Pretax Profit	-3.12	-7.50	-8.06	-6.85
Earnings After Tax	-3.12	-7.50	-8.06	-6.85
Profit Available For Dividend	0.00	0.00	0.00	0.00
Ordinary Dividends	0.00	0.00	0.00	0.00
Retained Profit	0.00	0.00	0.00	0.00
Shareholders Funds	-2.94	-3.68	21.98	15.44
Net Current Assets	0.00	0.00	0.00	0.00
Adjusted Earnings Per Share Undiluted	0.00	0.00	0.00	0.00
Adj Earnings Per Share	0.00	0.00	0.00	0.00
Dividend Per Share	0.00	0.00	0.00	0.00

Chart

Click here for interactive charting

Company Details
Address	935 Main Street, Waltham, MA 02451
Telephone	(781) 899 7755
Fax	(781) 899 8482
Executives
Chairman	Richard Clothier (0.00% holding)
Finance Director	David Frank (0.00% holding)
Non-Exec Director	Eric Steiner**** (5.90% holding)
Non-Exec Director	Elliot Entis** (1.90% holding)
Main Shareholders
	NANAF as Bay City Capital: 7.1% Western Pharmaceuticals S.A. & Corporation Farmaceutica Recalcine: 7.1% CSM Partners: 4.9% Lou Barnett*: 4.6%
Advisers
Nominated Adviser	Nomura
Nominated Broker	Nomura
Solicitors	Jones Day
Auditors	Ernst & Young
Registrar	Capita Registrars

Commentary
Develops and markets biotechnology products to enhance the profitability of shrimp and fish farming operations
Company Data
Code	ABTX
Sedol	USU7569610
Shares In Issue	49.966 m
Indices
Entry on AIM	20/03/2006
Interim Results	Sep
Final Results	May
Year End	Dec
Accounts Due	n/a
Int div payment	n/a
Fin div payment	n/a
Int net div per share	nil
Fin net div per share	nil
Probable CGT relief